Pravastatin Sodium
Product Images NDC 24689-142

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 24689-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apnar Pharma Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg_90ct (10mg 90ct)

This description provides details about the medication with NDC number 24689-140-02, which contains Pravastatin sodium USP 10 mg per tablet. The usual dosage information can be found in the package insert. The tablets should be stored at a temperature between 20° to 25°C (68° to 77°F) and protected from light and moisture. It is important to keep this and all drugs out of the reach of children. The medication is manufactured for APNAR PHARMA LP in Chino, CA, USA and is made in India. The package contains 90 tablets with a GTIN number of 00324689140025.*

FDA Label Image

20mg_1000ct (20mg 1000ct)

This is information on Pravastatin Sodium Tablets USP, with each tablet containing 20 mg of Pravastatin sodium. The usual dosage instructions are available in the package insert. The tablets should be stored at 20° to 25°C, protected from light and moisture, and kept out of reach of children. Manufactured for APNAR PHARMA LP in the USA, with a manufacturing license number G/25/2289. The tablets come in a package of 1000 tablets and have a GTIN number: 00324689141053. The product was made in India and has an unvarnished area of 30 x 76 mm.*

FDA Label Image

20mg_90ct (20mg 90ct)

This text is a label for a medication containing Pravastatin sodium USP 20 mg tablets. It provides information on storage conditions, dosage, manufacturer details, and a warning to keep the drug out of reach of children. The medication is dispensed in a tight, light-resistant container and should be protected from light and moisture. The manufacturer is listed as APNAR PHARMA LP located in Chino, CA, USA, with manufacturing done in India. The label also includes a GTIN code for identification.*

FDA Label Image

40mg_1000ct (40mg 1000ct)

This is a description of Pravastatin Sodium Tablets, USP, containing 40 mg of Pravastatin. The usual dosage instructions are provided in the package insert. It is recommended to store the tablets at 20° to 25°C and protect them from light and moisture in a tight, light-resistant container. The product is manufactured by APNAR PHARMA LP in Chino, CA, USA with a manufacturing license number G/25/2289. The tablets come in a pack of 1000 and are made in India. Additionally, the Global Trade Item Number (GTIN) for this product is 00324689142050.*

FDA Label Image

40mg_90ct (40mg 90ct)

This text provides information about a medication containing Pravastatin sodium USP 40 mg per tablet. It gives storage instructions, warnings about keeping the drug out of reach of children, and details on the manufacturer. The tablets are to be stored at a temperature range of 20°C to 25°C and should be protected from light and moisture. The drug is dispensed in a tight, light-resistant container. Additionally, the text includes a GTIN number for tracking purposes and mentions that the medication is manufactured in India for APNAR PHARMA LP based in Chino, CA, USA.*

FDA Label Image

80mg_90ct (80mg 90ct)

This description is a label for Pravastatin Sodium tablets that contain 80 mg of active ingredient per tablet. The medication is stored at a temperature range of 20°C to 25°C and should be protected from light and moisture. It is recommended to keep the tablets in a light-resistant container and out of reach of children. The tablets are manufactured for APNAR PHARMA LP based in Chino, CA, USA but are made in India. The label also includes the NDC code, dosage information, and expiration date.*

FDA Label Image

Graph-1 (Graph 1)

This is a data table presenting the proportion of subjects without an event (Coronary Heart Disease Death or Nonfatal Myocardial Infarction) over 5 years since randomization into the study for the placebo and pravastatin groups. The logrank statistic showed a significant difference between the two groups with a p-value of 0.0001. This information is useful for evaluating the effectiveness of pravastatin in reducing the risk of coronary events compared to placebo.*

FDA Label Image

Structure (Structure)

This text likely refers to a chemical compound or substance with the formula CyHasNaO and a molecular weight of 446.51. It may be used in chemical, pharmaceutical, or scientific contexts.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.